Skip to main content
. 2018 Nov 22;11:8265–8272. doi: 10.2147/OTT.S150807

Figure 1.

Figure 1

Schematic of the five clinical trials combined into a patient-level data meta-analysis of GO with standard induction therapy for frontline AML treatment.

Abbreviations: AML, acute myeloid leukemia; GO, gemtuzumab ozogamicin; OS, overall survival.